112190
112190 operates in various business sectors.
112190 (112190) - Net Assets
Latest net assets as of : ₩- KRW
Based on the latest financial reports, 112190 (112190) has net assets worth ₩- KRW as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩-) and total liabilities (₩-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
112190 - Net Assets Trend (None–None)
This chart illustrates how 112190's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for 112190 (None–None)
The table below shows the annual net assets of 112190 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to 112190's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
112190 Competitors by Market Cap
The table below lists competitors of 112190 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CPU Softwarehouse AG
F:CPU2
|
$7.36K |
|
RepliCel Life Sciences Inc
PINK:REPCF
|
$7.36K |
|
MagForce AG
PINK:MGFRF
|
$7.37K |
|
Enzychem Lifesciences Corporation
KO:183490
|
$7.37K |
|
TRANSGENE (TGNA.SG)
STU:TGNA
|
$7.35K |
|
El Nasr For Manufacturing Agricultural Crops
EGX:ELNA
|
$7.34K |
|
ARML3F
SA:ARML3F
|
$7.33K |
|
Hall of Fame Village LLC
NASDAQ:HOFVW
|
$7.33K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in 112190's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares 112190's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently 112190 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares 112190's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.